Literature DB >> 22858367

An uncommon complication of infective bacterial endocarditis.

Joey Yeoh1, Tina Sun, Mark Hobbs, Jen-Li Looi, Selwyn Wong.   

Abstract

Coronary artery septic embolisation resulting in cardioembolic myocardial infarction (MI) is a rare complication of bacterial infective endocarditis (IE), representing <1% of complications related to IE. Diagnosis requires a combination of high clinical suspicion, coronary angiography, echocardiography and cultures of peripheral blood and/or embolic material. The associated mortality rate remains high despite early diagnosis. Optimal interventional therapy is unknown with published international experience over the past two decades limited to very small case series and individual case reports. We present a case of ST elevation MI resulting from coronary artery septic embolisation with an accompanying comprehensive review of the literature. Crown
Copyright © 2012. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22858367     DOI: 10.1016/j.hlc.2012.05.004

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  3 in total

Review 1.  Septic coronary artery embolism treated with aspiration thrombectomy: case report and review of literature.

Authors:  Khawar Maqsood; Nosheen Sarwar; Hossein Eftekhari; Amir Lotfi
Journal:  Tex Heart Inst J       Date:  2014-08-01

2.  Infective endocarditis as a rare cause for acute limb ischemia.

Authors:  George Galyfos; Sotirios Giannakakis; Stavros Kerasidis; Georgios Geropapas; Georgios Kastrisios; Gerasimos Papacharalampous; Chrisostomos Maltezos
Journal:  World J Emerg Med       Date:  2016

3.  Infective endocarditis complicated with nonobstructive ST elevation myocardial infarction related to septic embolism with intracranial hemorrhage: A case report.

Authors:  Yi-Hsueh Liu; Wen-Hsien Lee; Chun-Yuan Chu; Ho-Ming Su; Tsung-Hsien Lin; Hsueh-Yei Yen; Wen-Chol Voon; Wen-Ter Lai; Sheng-Hsiung Sheu; Po-Chao Hsu
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.